@article{Reddy_S-2024_189964,
title = {Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies},
author = {Reddy, S. and Newman, J. and Leavy, O. and Ghani, H. and Pepke-Zaba, J. and Cannon, J. and Sheares, K. and Taboada, D. and Bunclark, K. and Lawrie, A. and Sudlow, C. and Berry, C. and Wild, J. and Mitchell, J. and Quint, J. and Rossdale, J. and Price, L. and Howard, L. and Wilkins, M. and Sattar, N. and Chowienczyk, P. and Thompson, R. and Wain, L. and Horsley, A. and Ho, L. and Chalmers, J. and Marks, M. and Poinasamy, K. and Raman, B. and Harris, V. and Houchen-Wolloff, L. and Brightling, C. and Evans, R. and Toshner, M.},
month = {aug},
year = {2024},
abstract = {Background Pulmonary embolism (PE) is a well-recognised complication of coronavirus disease 2019 (COVID-19) infection, and chronic thromboembolic pulmonary disease with and without pulmonary hypertension (CTEPD/CTEPH) are potential life-limiting consequences. At present the burden of CTEPD/ CTEPH is unclear and optimal and cost-effective screening strategies yet to be established.},
volume = {64},
issue = {2},
journal = {European Respiratory Journal},
publisher = {ERS Publications},
url = {https://doi.org/10.1183/13993003.01742-2023},
}
